Otonomy Inc's ear drug fails mid-stage trial
May 21, 2015 at 16:32 PM EDT
May 21 (Reuters) - Drug developer Otonomy Inc said its experimental drug did not meet the main goal of reducing the incidence of vertigo in a mid-stage trial in patients suffering from Ménière's disease.